5 Pharmaceutical products for the treatment of Parkinson's disease and neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases; pharmaceutical preparations for the treatment of Parkinson's disease and neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis and acute liver failure, Age-related macular degeneration and limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases; stem cells for medical or veterinary use; pluripotent stem cells intended for cell and gene therapies for medical use; cell culture media for medical or veterinary use, namely, culture media for cultivating human cells and microorganism cells; surgical implants comprising living tissue obtained from stem cells